« The DNA Network: Group of Genetics Bloggers | Home | Odd Ways to Find Us Through a Search Engine »
Global Epigenomics Market to Reach $4.1 Billion by 2012
By Trevor | May 11, 2007
“$4.1 Billion by 2012″ is the major finding of a market report on the global epigenomics market published by BCC Research. The report identified three key market segments that will be commercially important in the field of epigenomics in the next 5 years: research tools, cancer diagnostics, and cancer therapeutics.
There are three major highlights from the report (which I have not read in its entirety due to its cost):
- The global market for epigenomics was $161.8 million in 2005 and $263.2 million in 2006. The market will cross $385 million by 2007 and at a compound annual growth rate (CAGR) of 60.4% will reach nearly $4.1 billion by 2012.
- Drug applications for epigenetics are by far the largest sector of the market. These drugs will hold 61% of the total global market in 2007 and will grow to over a 65% market share by 2012.
- Epigenetic diagnostics has the most potential for growth through the forecast period. In 2006 and 2007 its applications were negligible, but by 2012 this booming sector will be worth over $947 million.
The full market report is available for US$4,850. Link
Related Posts:
Topics: investors |
Comments are closed.
